# Chloroquine for Reducing Immune Activation in HIV- Infected Individuals

> **NCT00819390** · PHASE2 · COMPLETED · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 70 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Chloroquine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00819390
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2013-02
- **Final completion:** 2013-05
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2014-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00819390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00819390, "Chloroquine for Reducing Immune Activation in HIV- Infected Individuals". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00819390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*